• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

CNS Summit 2017 Abstracts of Poster Presentations
Conclusion: This novel technology discriminates and quantifies subtle differences in behavior and neurological impairments in subjects afflicted with neurological injury/disease. KINARM assessments can be incorporated into multi-center trials (e.g., monitoring stroke motor recovery: NCT02928393). Further studies will determine if KINARM Labs can demonstrate a clinical effect with fewer subjects over a shorter trial period. Disclosures/funding: Dr. Stephen Scott is the inventor of KINARM and CSO of BKIN Technologies.   Multiplexed mass spectrometry assay identifies neurodegeneration biomarkers in CSF Presenter: Chelsky...
Source: Innovations in Clinical Neuroscience - November 1, 2017 Category: Neuroscience Authors: ICNS Online Editor Tags: Assessment Tools biomarkers Cognition Current Issue Drug Development General Genetics Medical Issues Neurology Patient Assessment Psychopharmacology Scales Special Issues Supplements Trial Methodology clinical trials CNS Su Source Type: research

The P300 in middle cerebral artery strokes or hemorrhages: Outcome predictions and source localization
Stroke is the leading cause of disability and is the third leading cause of death worldwide (Murray and Lopez, 1997). According to the World Health Organisation, a total of 15 million people suffer a stroke each year. Strokes can principally be classified into two main categories, ischemic and hemorrhagic (Donnan et al., 2008). 85% of all strokes are of ischemic origin (Qureshi et al., 2001) and most commonly occur within the territory of the middle cerebral artery (MCA). The MCA supplies the lateral portion of the cerebral cortex (about 60–70% of the hemisphere).
Source: Clinical Neurophysiology - November 1, 2014 Category: Neuroscience Authors: Mana R. Ehlers, Carmen López Herrero, Andreas Kastrup, Helmut Hildebrandt Source Type: research

The P300 in middle cerebral artery strokes or hemorrhages: outcome predictions and source localisation
Stroke is the leading cause of disability and is the third leading cause of death worldwide (Murray and Lopez, 1997). According to the World Health Organisation, a total of 15 million people suffer a stroke each year. Strokes can principally be classified into two main categories, ischemic and hemorrhagic (Donnan et al., 2008). 85 % of all strokes are of ischemic origin (Qureshi et al., 2001) and most commonly occur within the territory of the middle cerebral artery (MCA). The MCA supplies the lateral portion of the cerebral cortex (about 60 % - 70 % of the hemisphere).
Source: Clinical Neurophysiology - November 1, 2014 Category: Neuroscience Authors: Mana R. Ehlers, Carmen López Herrero, Andreas Kastrup, Helmut Hildebrandt Source Type: research